Strive Financial Group
EW icon

Strive Financial Group’s Edwards Lifesciences EW Stock Holding History

Strive Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.4K Buy
+202
New +$18K 0.01% 579

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Strive Financial Group's EW Position: Q3 2026 in Review

Strive Financial Group opened a new position in Edwards Lifesciences (EW) in Q3 2026: 202 shares worth $17.4K. The stake represents 0.01% of the portfolio and ranks #579 among its holdings.

1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Strive Financial Group held 202 shares of Edwards Lifesciences worth $17.4K as of Q3 2026.
  • Edwards Lifesciences was a new Strive Financial Group position in Q3 2026.
  • Edwards Lifesciences made up 0.01% of Strive Financial Group's portfolio in Q3 2026, its #579 holding.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Strive Financial Group's 13F filing for Q3 2026, filed 9 Nov 2026.